are glp 1 drugs safe long term Why Is Everyone Excited About GLP-1 Medication? Mapping the effectiveness and risks
Description
Lancet 394(10193):121130 Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, TECOS Study Group et al (2015) Effect of Sitagliptin on cardiovascular outcomes in type 2 diabetes
If ongoing trials continue to deliver positive results, triple agonist therapies for diabetes may represent the next major evolution in treating obesity, type 2 diabetes, and related metabolic diseases
Yet, the practical impact has been minimal
The GLP-1 component reaches a threshold level that produces noticeable changes in hunger patterns and food preferences
